service de pneumologie, CHU St Pierre
Brussels, 1000, Belgium
NCT Number: NCT01937494
Bronchial hyperresponsiveness consists in excessive response to bronchial stimuli.Bronchial challenge test is used to confirm/exclude asthma (metacholine or histamine).Protection are used to avoid passive exposure of the technicians performing the test, despite the absence of evidence that they could develop a bronchoconstriction even if they suffer from BHR.The purpose of the study is to determine if patients with a high level of bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge, are developing a bronchoconstriction, when placed in the same conditions that the technicians performing these tests.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Brussels, 1000, Belgium
Bronchial hyperresponsiveness (BHR) consists in excessive response to bronchial stimuli.Bronchial challenge test is used to confirm/exclude asthma.BHR is also present in other diseases such as allergic rhinitis, Chronic Obstructive pulmonary disease,heart failure..
Thes test is performed with metacholine or histamine with spirometric documented response to incremental doses.Protection are used to avoid passive exposure of the technicians performing the test, despite the absence of evidence that they could develop a bronchoconstriction if they suffer from BHR.
The purpose of the study is to determine if patients, newly diagnosed with a high level of bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge, are reacting to histamine when placed in the same conditions that the technicians performing these tests.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
passive exposure to histamine during a bronchial hyperresponsiveness challenge
Time frame: 1 hour
Centre Hospitalier Universitaire Saint Pierre
Other
Are Technicians Showing Bronchial Hyperreactivity Able to Safely Perform Bronchial Provocation Tests?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01006655
Asthma, Bronchial Diseases
Haifa, Israel
View Trial DetailsNCT00541255
Asthma, Bronchial Diseases
Newport, Isle Of Wight, United Kingdom
View Trial DetailsNCT00232999
Asthma, Bronchial Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT00455923
Asthma, Bronchial Diseases
Luleå, Sweden
View Trial Details